Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get in-depth and insightful information about the pharmaceutical and medtech industries with pharmaceutical whitepapers from Pharma Intelligence. Covering a range of topics and specialty areas, these informative and authoritative whitepapers present insights and information not found elsewhere.
92 Total results for product and free and sample content found
Citeline
10 Jan 2020
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
Topic Cancer Clinical Trials Research
Pharma Consulting
By Duncan Emerton 04 Nov 2019
If you’re looking at the opportunities to increase revenue and mitigate current and future threats by formulating the strongest biosimilars strategy, Informa’s Biosimilars Insights and Analysis Service is the tool you need.
Topic Biosimilars
Datamonitor Healthcare
By Hannah Cohen 25 Oct 2019
Explore the key hurdles to anticipating the initial and potential value of the NASH therapy market.
Meddevicetracker
02 Aug 2019
Find and manipulate the essential medical devices and diagnostics market intelligence you rely on from Meddevicetracker’s Market Analysis Reports with Meddevicetracker’s new interactive Market Analysis tool.
Datamonitor Healthcare
15 Jul 2019
Our latest whitepaper lists the top selling drugs last year, who developed them and the strategies behind their success. We drew from three of our top products to create our most recent whitepaper, Datamonitor Health Care, Biomedtracker and Pharmaprojects. You can experience them all for yourself.
Topic Drug review Strategy Deal trends
Datamonitor Healthcare
03 Jul 2019
This essential whitepaper looks at how increased drug spending and a rising desire for expenditure controls are influencing access dynamics across key markets. It is available to you now, for free.
Citeline
By Christine Blazynski, PhD 25 Jun 2019
The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. Industry-sponsored clinical trials across all oncology indications covered by Informa Pharma Intelligence’s Trialtrove were assessed, comparing metrics by company size based on pharma sales, and the identical benchmarks for breast cancer and rare cancers were also analyzed.
Topic Clinical trials Cancer
Datamonitor Healthcare
15 Jun 2019
In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This exploration into the results of a recent analysis of the US Behavioral Risk Factor Surveillance System (BRFSS), coupled with an analysis of several health apps targeting coronary heart disease (CHD) and other heart disease factors, is available to you now – for free.
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
